Effects of Knee-extensor Exercise Training in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
COPD patients have a reduced exercise tolerance due to a ventilatory limitation.
Several studies have shown altered skeletal muscle function. The investigator will study the physiological response to knee-extensor exercise in COPD patients.
| Condition | Intervention |
|---|---|
|
Chronic Obstructive Pulmonary Disease |
Behavioral: High intensity knee-extensor training |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Effects of Knee-extensor Exercise Training in Chronic Obstructive Pulmonary Disease (COPD) Patients |
- Peak power [ Time Frame: At inclusion and after 6 weeks of training ] [ Designated as safety issue: No ]
- Mitochondrial respiration, Vmax [ Time Frame: At inclusion and after 6 weeks of training ] [ Designated as safety issue: No ]
| Enrollment: | 12 |
| Study Start Date: | February 2009 |
| Study Completion Date: | December 2012 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Knee extensor exercise training
High intensity aerobic knee-extensor exercise training
|
Behavioral: High intensity knee-extensor training
High intensity aerobic knee-extensor exercise training, 4x 3 minutes interval training at < 90 % of peak power, 3 days/week for 6 weeks
|
Detailed Description:
Reduced exercise tolerance is one of the hallmarks of COPD. The principal causes for exercise intolerance are ventilatory limitation leading to deconditioning and inactivity. However the weak correlation between exercise capacity and FEV1 implies that other factors than reduced pulmonary function contribute to this impairment as well. Several studies have found changes in skeletal muscle, with fibre shift, increased oxidative stress, increased inflammatory cytokines and impaired mitochondrial function, suggesting a lower limb dysfunction.
Numerous exercise studies in COPD patients have shown physiological and physiological benefits of training and endurance training is now regarded as an important part in pulmonary rehabilitation.
In this study we investigate training effects in patients with moderate to severe COPD with special focus on skeletal muscle.
COPD patients will perform high intensity aerobic interval knee-extensor exercise training 3 days/week for six weeks . At baseline and follow-up, muscle oxygen consumption and mitochondrial respiration will be measured.
Eligibility| Ages Eligible for Study: | 50 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- COPD diagnosis with FEV1<70% exp, FEV1%FVC <70 %
- Age> 50 years
Exclusion Criteria:
- Heart failure
- Symptomatic coronary artery disease
- Cancer
- Alcohol and drug abuse
- Severe mental illness
- Lower respiratory illness
- Participation in exercise- or lung rehabilitation program last 3 months
- pregnancy
- oral steroid use
Contacts and Locations
More Information
No publications provided by Norwegian University of Science and Technology
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT01079221 History of Changes |
| Other Study ID Numbers: | 42009297 |
| Study First Received: | March 2, 2010 |
| Last Updated: | April 8, 2013 |
| Health Authority: | Norway: Norwegian Social Science Data Services Norway: Ministry of Health and Care Services Norway:National Committee for Medical and Health Research Ethics |
Keywords provided by Norwegian University of Science and Technology:
|
exercise Knee extensor |
Additional relevant MeSH terms:
|
Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 17, 2013